Given this unifying pathophysiology, GLP-1 RAs, with their powerful ability to act both centrally (controlling appetite and cravings) and peripherally (correcting systemic metabolic dysfunction, resolving hepatic steatosis and inflammation), to exert direct anti-carcinogenic effects, represent a truly multi-functional therapeutic tool
Eli Lilly: Still the industry leader Novo Nordisk was first to market, but Eli Lilly's GLP-1 shot proved more effective
A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of Alzheimers disease and related dementias in patients with Type 2 diabetes
GLP-1R agonists have reducing neuroinflammation and oxidative stress, neurotrophic effects, decreasing A deposition and tau hyperphosphorylation in AD models, which may be a potential drug for the treatment of AD
Id frame it as a helpful tool for some, not a replacement. OEA might be a good option for those who are already making lifestyle changes (like eating well, exercising, and tracking habits), but need an extra nudge with appetite control, such as with late-night cravings or portion control, says Dr